These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7416837)

  • 1. Systemic-Pulmonary shunts inneonates and infants using microporous expanded polytetrafluoroethylene: immediate and late results.
    Donahoo JS; Gardner TJ; Zahka K; Kidd BS
    Ann Thorac Surg; 1980 Aug; 30(2):146-50. PubMed ID: 7416837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic-pulmonary shunts in infants and children. Early and late results.
    Lamberti JJ; Carlisle J; Waldman JD; Lodge FA; Kirkpatrick SE; George L; Mathewson JW; Turner SW; Pappelbaum SJ
    J Thorac Cardiovasc Surg; 1984 Jul; 88(1):76-81. PubMed ID: 6204171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subclavian-pulmonary artery shunts with polytetrafluorethylene interposition grafts.
    Bove EL; Sondheimer HM; Kavey RE; Byrum CJ; Blackman MS; Parker FB
    Ann Thorac Surg; 1984 Jan; 37(1):88-91. PubMed ID: 6691743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of Blalock-Taussig, Waterston, and polytetrafluoroethylene shunts in children less than two weeks of age.
    Woolf PK; Stephenson LW; Meijboom E; Bavinck JH; Gardner TJ; Donahoo JS; Edie RN; Edmunds LH
    Ann Thorac Surg; 1984 Jul; 38(1):26-30. PubMed ID: 6203495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of microporous expanded polytetrafluoroethylene grafts for aorta-pulmonary shunts in infants with complex cyanotic heart disease. A report of seven cases.
    Jennings RB; Innes BJ; Brickman RD
    J Thorac Cardiovasc Surg; 1978 Oct; 76(4):489-94. PubMed ID: 703356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The modified blalock-taussig shunt using microporous expanded polytetrafluoroethylene (PTFE).
    Lawless CE; Smith EE; Hallidie-Smith K; Sapsford RN
    J Cardiovasc Surg (Torino); 1982; 23(4):287-92. PubMed ID: 7107686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blalock-Taussig shunts and modified Blalock-Taussig shunts.
    Sanchez HE; Vosloo S
    S Afr Med J; 1985 Feb; 67(5):168-70. PubMed ID: 3983755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic-pulmonary polytetrafluoroethylene shunts in palliative operations for congenital heart disease. Revival of the central shunt.
    Amato JJ; Marbey ML; Bush C; Galdieri RJ; Cotroneo JV; Bushong J
    J Thorac Cardiovasc Surg; 1988 Jan; 95(1):62-9. PubMed ID: 2447447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aorta-pulmonary artery shunts with expanded polytetrafluoroethylene (PTFE) tube.
    Miyamoto K; Zavanella C; Lewin AN; Subramanian S
    Ann Thorac Surg; 1979 May; 27(5):413-7. PubMed ID: 454015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experience with the modified Blalock-Taussig operation using polytetrafluoroethylene (Impra) grafts.
    Kay PH; Capuani A; Franks R; Lincoln C
    Br Heart J; 1983 Apr; 49(4):359-63. PubMed ID: 6830670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress of patients with pulmonary atresia after systemic to pulmonary arterial shunts.
    Calder AL; Chan NS; Clarkson PM; Kerr AR; Neutze JM
    Ann Thorac Surg; 1991 Mar; 51(3):401-7. PubMed ID: 1705418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postoperative angiographic assessment of modified Blalock-Taussig shunts using expanded polytetrafluoroethylene (Gore-Tex).
    McKay R; de Leval MR; Rees P; Taylor JF; Macartney FJ; Stark J
    Ann Thorac Surg; 1980 Aug; 30(2):137-45. PubMed ID: 7416836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of microporous-expanded polytetrafluoroethylene (PTFE) in systemic-pulmonary shunts in infants].
    Gomez R; Frenandez R; Guttierez J; Perez J; Verduras MJ; Sanchez P; Quero M; Brito JM
    Ann Chir; 1983 Mar; 37(2):169-74. PubMed ID: 6680817
    [No Abstract]   [Full Text] [Related]  

  • 14. The Blalock-Taussig shunt in infants: standard versus modified.
    Ullom RL; Sade RM; Crawford FA; Ross BA; Spinale F
    Ann Thorac Surg; 1987 Nov; 44(5):539-43. PubMed ID: 3675059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central aorta-pulmonary artery shunts in neonates with complex cyanotic congenital heart disease.
    Barragry TP; Ring WS; Blatchford JW; Foker JE
    J Thorac Cardiovasc Surg; 1987 May; 93(5):767-74. PubMed ID: 3573789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arterial prosthesis of microporous expanded polytetrafluoroethylene for construction of aorta-pulmonary shunts.
    Gazzaniga AB; Lamberti JJ; Siewers RD; Sperling DR; Dietrick WR; Arcilla RA; Replogle RL
    J Thorac Cardiovasc Surg; 1976 Sep; 72(3):357-63. PubMed ID: 957753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neonatal Blalock-Taussig shunt: technical aspects and postoperative management.
    Swain SK; Dharmapuram AK; Reddy P; Ramdoss N; Raghavan SS; Kona SM
    Asian Cardiovasc Thorac Ann; 2008 Jan; 16(1):7-10. PubMed ID: 18245697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modified Blalock-Taussig shunt. Use of subclavian artery orifice as flow regulator in prosthetic systemic-pulmonary artery shunts.
    de Leval MR; McKay R; Jones M; Stark J; Macartney FJ
    J Thorac Cardiovasc Surg; 1981 Jan; 81(1):112-9. PubMed ID: 6450303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A five-year clinical experience with 112 Blalock-Taussig shunts.
    Gold JP; Violaris K; Engle MA; Klein AA; Ehlers KH; Lang SJ; Levin AR; Moran F; O'Loughlin JE; Snyder MS
    J Card Surg; 1993 Jan; 8(1):9-17. PubMed ID: 8422496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Twelve year experience with the modified Blalock-Taussig shunt in neonates.
    Fermanis GG; Ekangaki AK; Salmon AP; Keeton BR; Shore DF; Lamb RK; Monro JL
    Eur J Cardiothorac Surg; 1992; 6(11):586-9. PubMed ID: 1449812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.